05/14/2024
3:18 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
3:19 PM | Taysha Gene Therapies (Filer)
| Form ARS | |
04/18/2024
3:21 PM | Taysha Gene Therapies (Filer)
| Form DEFA14A | |
03/19/2024
3:55 PM | Taysha Gene Therapies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
7:44 PM | Taysha Gene Therapies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
6:08 AM | RTW INVESTMENTS, LP (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G/A | |
|
02/06/2024
3:42 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
7:06 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:41 PM | Nolan Sean P. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:42 PM | Nagendran Sukumar (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:43 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:20 PM | Taysha Gene Therapies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/20/2023
3:21 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:50 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:46 PM | Nolan Sean P. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:47 PM | Nagendran Sukumar (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
6:35 AM | Manning Paul B (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
3:29 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
3:47 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
3:17 PM | Taysha Gene Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/03/2023
3:40 PM | Long Alison S (Reporting)
Taysha Gene Therapies (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/03/2023
3:41 PM | Long Alison S (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
6:00 AM | Taysha Gene Therapies (Filer)
| Form DEF 14A | |
09/26/2023
7:08 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
3:01 PM | Taysha Gene Therapies (Filer)
| Form PRE 14A | |
09/11/2023
7:23 AM | FMR LLC (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G/A | |
09/10/2023
11:15 PM | Taysha Gene Therapies (Filer)
| Form EFFECT | |
08/29/2023
6:00 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/25/2023
4:01 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G | |
08/25/2023
3:30 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
4:33 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/24/2023
7:09 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
4:16 PM | Astellas Pharma Inc. (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13D/A | |
08/16/2023
7:57 PM | Manning Paul B (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
7:51 PM | Donenberg Phillip B. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
7:52 PM | Nolan Sean P. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
7:53 PM | Stalfort John A III (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
7:36 AM | Taysha Gene Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:29 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
7:05 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Everybody laughed when he recommended Netflix (Ad) "This Could be Worth Even More than A.I."
Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. |
07/14/2023
3:00 PM | Session R.A. II (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
7:31 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
3:48 PM | Stalfort John A III (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:49 PM | Donenberg Phillip B. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:50 PM | Reape Kathleen (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:50 PM | Sepp-Lorenzino Laura (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:46 PM | Session R.A. II (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:46 PM | Stalfort John A III (Reporting)
Taysha Gene Therapies (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2023
4:27 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2023
4:12 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
6:14 PM | Session R.A. II (Reporting)
Taysha Gene Therapies (Subject)
| Form 144/A | |
06/20/2023
3:52 PM | Session R.A. II (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
7:20 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
8:24 PM | Porter Fred (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
8:25 PM | McAuliffe Sean (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
